T-cell costimulatory pathways in allograft rejection and tolerance (Q35583511)

9 August 2017

1 reference

title

T-cell costimulatory pathways in allograft rejection and tolerance. (English)

1 reference

9 August 2017

David M Rothstein

1

1 reference

9 August 2017

Mohamed H Sayegh

series ordinal

2

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

published in

Immunological Reviews

1 reference

9 August 2017

volume

196

1 reference

9 August 2017

page(s)

85-108

1 reference

The role of T-cell costimulatory activation pathways in transplant rejection

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

T-cell regulation by CD28 and CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Ordered just so: lipid rafts and lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The CD40 pathway in allograft rejection, acceptance, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD28-independent costimulation of T cells in alloimmune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The interaction properties of costimulatory molecules revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

B7/CD28 costimulation is essential for the homeostasis of the CD4 CD25 immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Immunologic self-tolerance maintained by CD25( )CD4( ) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Structural analysis of CTLA-4 function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Molecular basis of T cell inactivation by CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25 cells, and the alloreactive T cell clone size

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The role of TNF receptor and TNF superfamily molecules in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD40 ligand (CD154) triggers a short-term CD4( ) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

A conditioned dendritic cell can be a temporal bridge between a CD4 T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Immature, but not inactive: the tolerogenic function of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Tumor necrosis factor receptor-associated factors (TRAFs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Challenges to achieving clinical transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD4( )CD25( ) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

LICOS, a primordial costimulatory ligand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Characterization of human inducible costimulator ligand expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

T cell co-stimulatory molecules other than CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

ICOS co-stimulatory receptor is essential for T-cell activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

ICOS is critical for CD40-mediated antibody class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

ICOS is essential for effective T-helper-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

PD-1:PD-L inhibitory pathway affects both CD4( ) and CD8( ) T cells and is overcome by IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Programmed death-1 targeting can promote allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Identification of rat OX40 ligand by molecular cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

OX-40: life beyond the effector T cell stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

4-1BB costimulatory signals preferentially induce CD8 T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Role of 4-1BB in Allograft Rejection Mediated by CD8 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Tumor necrosis factor receptor family members in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD27 is required for generation and long-term maintenance of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Characterization of murine CD70 by molecular cloning and mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Alternative T-cell costimulatory pathways in transplant rejection and tolerance induction: hierarchy or redundancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

T lymphocyte costimulation mediated by reorganization of membrane microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8 T cells and prolonged graft survival in a CTLA4-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28−/− mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

CD27-mediated activation of murine NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1600-065X.2003.00088.X

10.1046/J.1600-065X.2003.00088.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference